Activated matrix metalloproteinase-2 - A potential marker of prognosis for epithelial ovarian cancer

Gynecologic Oncology

Volumn 84, Issue 1, 2002, Pages 126-134

  Wu, Xiaohua ^a   Li, Haili ^a   Kang, Lin ^a   Li, Li ^a   Wang, Weiping ^a   Shan, Baoen ^a  

^a HEBEI MEDICAL UNIVERSITY   (China)

Author keywords

MMP 2; mRNA; Ovarian neoplasms; RT PCR; Western blot

Indexed keywords

BIOCHEMICAL MARKER; GELATINASE A;

ADULT; AGED; ARTICLE; CANCER INVASION; CLINICAL FEATURE; DISEASE COURSE; ENZYME ACTIVATION; EPITHELIUM CELL; FEMALE; FIBROBLAST; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; METASTASIS; OVARY CARCINOMA; OVARY TUMOR; PRIORITY JOURNAL; PROGNOSIS; PROTEIN EXPRESSION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; TUMOR CELL; WESTERN BLOTTING;

EID: 0036142697     PISSN: 00908258     EISSN: None     Source Type: Journal    
DOI: 10.1006/gyno.2001.6477     Document Type: Article

References (34)

1. National Institutes of Health consensus development conference statement: Ovarian cancer: Screening, treatment, and follow-up
2. In vitro degradation of extracellular matrix by human ovarian carcinoma cells
3. Matrix metalloproteinase-2 and tissue inhibitor of metalloproteinase-2 expression and synthetic matrix metalloproteinase-2 inhibitor binding in ovarian carcinomas and tumor cell lines
4. Proteolytic remodeling of extracellular matrix
5. Basement membrane status I undifferentiated carcinomas of the ovary: Immunohistochemical distribution of type IV collagen and laminin
6. A matrix metalloproteinase expressed on the surface of invasive tumor cells
7. Activation of progelatinase A and progelatinase A/TIMP-2 complex by membrane type2 - Matrix metalloprgteinase
8. Expression of three matrix metalloproteinases (MT-MMPs) in rat vascular smooth muscle cells and characterization of MT3-MMPs with and without transmembrane domain
9. Mechanism of cell surface activation of 72 kDa type IV collagenase
10. Intermolecular autolytic cleavage can contribute to the activation of progelatinase A by cell membrane
11. Involvement of PA/plasmin system in the processing of pm-MMP-9 and in the second step of proMMP-2 activation
12. Tissue inhibitor of metalloproteinases-2 (TIMP-2) mRNA expression in tumor cell lines and human tumor tissues
13. Tissue inhibitor of metalloproteinase-2 (TIMP-2) binds to the catalytic domain of the cell surface receptor, membrane type matrix metalloproteinase 1 (MT1-MMP)
14. The TIMP-2 membrane type metalloproteinase "receptor" regulates the concentration and efficient activation of progelatinase A. A kinetic study
15. Human 72 kilodalton type IV collagenase forms a complex with a tissue inhibitor of metalloproteinases designated TIMP-2
16. Activation mechanism of matrix metalloproteinases
17. Single-step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction
18. Gelatinase A/TIMP-2 imbalance in lymph-node-positive breast carcinoma, as measured by RT-PCR
19. Gelatinase A-immunoreactive protein in ovarian lesions - Prognostic value in epithelial ovarian cancer
20. Laser capture microdissection: Molecular analysis of tissue
21. Expression of 72 kilodalton type IV collagenase (gelatinase A) in benign and malignant ovarian rumors
22. Expression and activity of MMPs and their regulators in ovarian cancer
23. Tissue and serum metalloproteinase (MMP-2) expression in advanced ovarian serous cystoadenocarcinomas: Clinical and prognostic implications
24. The family of matrix metalloproteinases
25. Evaluation of basement membrane components and the 72 kDa type IV collagenase in serous tumors of the ovary
26. MT1-MMP and MMP-2 mRNA expression in human ovarian tumors: Possible implications for the role desmoplastic fibroblasts
27. MMP-2 release and activation in ovarian carcinoma: The role of fibroblasts
28. Membrane-type matrix-metalloproteinase (MT-MMP) gene is expressed in stromal cells of human colon, breast, and head-and-neck carcinomas
29. Activation of fibroblast-derived matrix metalloproteinase-2 by colon-cancer cells in non-contact co-cultures
30. Dual over-expression pattern of membrane-type metalloproteinase-1 in cancer and stromal cells in human gastrointestinal carcinoma revealed by in situ hybridization and immnno-electron microscopy
31. Membrane-type matrix metalloproteinase expression and matrix metalloproteinase-2 activation in primary human ovarian epithelial carcinoma cells
32. The role of tissue microdissection in cancer research
33. Characterization of extracellular matrix-degrading proteinase and its inhibitor in gynecologic cancer tissues with clinically different metastatic form
34. Characterization of gelatinases linked to extracellular matrix invasion in ovarian adenocarcinoma: Purification of matrix metalloproteinase 2